(S1 (S (S (NP (JJ Alpha-melanocyte-stimulating) (NN hormone)) (VP (VBZ modulates) (NP (NP (NP (NN activation)) (PP (IN of) (NP (NP (NN NF-kappa) (NN B)) (CC and) (NP (NN AP-1))))) (CC and) (NP (NP (NN secretion)) (PP (IN of) (NP (NN interleukin-8))) (PP (IN in) (NP (JJ human) (JJ dermal) (NNS fibroblasts))))))) (. .)))
(S1 (S (S (NP (NP (JJ Alpha-melanocyte-stimulating) (NN hormone)) (PRN (-LRB- -LRB-) (NP (NN alpha-MSH)) (-RRB- -RRB-))) (VP (VBZ has) (VP (VBN evolved) (PP (IN as) (NP (NP (DT a) (NN mediator)) (PP (IN of) (NP (NP (JJ diverse) (JJ biological) (NNS activities)) (PP (IN in) (NP (NP (DT an) (JJ ever-growing) (NN number)) (PP (IN of) (NP (JJ non-melanocytic) (NN cell) (NNS types)))))))))))) (. .)))
(S1 (S (S (NP (NP (CD One) (NN mechanism)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (NN alpha-MSH)) (VP (VBZ exerts) (NP (PRP$ its) (NNS effects)))))) (VP (VBZ is) (NP (NP (NN modulation)) (PP (IN of) (NP (NP (NN AP-1)) (CC and) (NP (NN NF-kappa) (NN B))))))) (. .)))
(S1 (S (S (NP (DT These) (CD two) (NN transcription) (NNS factors)) (ADVP (RB also)) (VP (VBP play) (NP (DT an) (JJ important) (NN role)) (PP (PP (IN in) (NP (NNS fibroblasts))) (, ,) (PP (IN in) (NP (JJ extracellular) (NN matrix) (NN composition))) (, ,) (CC and) (PP (IN in) (NP (NN cytokine) (NN expression)))))) (. .)))
(S1 (S (S (PP (IN By) (NP (NP (NN use)) (PP (IN of) (NP (JJ electric) (NN mobility) (NN shift) (NNS assays))))) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (NN alpha-MSH)) (PRN (-LRB- -LRB-) (NP (CD 10-LRB--6-RRB-) (TO to) (CD 10-LRB--14-RRB-) (NN M)) (-RRB- -RRB-))) (VP (VBZ activates) (NP (NN AP-1)) (PP (IN in) (NP (JJ human) (JJ dermal) (NNS fibroblasts))) (, ,) (SBAR (IN whereas) (S (NP (NP (NN coincubation)) (PP (IN with) (NP (NP (NN interleukin-1) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN IL-1) (NN beta)) (-RRB- -RRB-))))) (VP (VBZ results) (PP (IN in) (NP (NP (NN suppression)) (PP (IN of) (NP (PRP$ its) (NN activation))))))))))))) (. .)))
(S1 (S (S (NP (NN alpha-MSH)) (ADVP (RB also)) (VP (VP (VBZ induces) (NP (NP (NN activation)) (PP (IN of) (NP (NN NF-kappa) (NN B))))) (CC but) (VP (VBZ does) (RB not) (VP (VB modulate) (NP (NN DNA) (NN binding)) (PP (IN on) (NP (NP (NN costimulation)) (PP (IN with) (NP (NN IL-1) (NN beta))))))))) (. .)))
(S1 (S (S (SBAR (IN Since) (S (NP (NP (NN AP-1)) (CC and) (NP (NN NF-kappa) (NN B))) (VP (VBP are) (NP (NP (JJ key) (NNS elements)) (PP (IN in) (S (VP (VBG controlling) (NP (NN interleukin-8) (-LRB- -LRB-) (NN IL-8) (-RRB- -RRB-) (NN transcription))))))))) (, ,) (S (S (NP (JJ human) (NNS fibroblasts)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (NN alpha-MSH)) (CC and) (NP (NN IL-1) (NN beta)))) (PP (IN for) (NP (CD 24) (NNS hours)))))) (, ,) (CC and) (S (NP (NP (NN cytokine) (NNS levels)) (PP (IN in) (NP (DT the) (NNS supernatants)))) (VP (VBD were) (VP (VBN measured) (PP (IN by) (S (NP (NN ELISA.) (NN alpha-MSH)) (ADVP (RB alone)) (VP (VBD had) (NP (JJ little) (NN effect)) (, ,) (SBAR (IN whereas) (S (NP (NP (NN coincubation)) (PP (IN with) (NP (NN IL-1) (NN beta)))) (VP (VBD led) (PP (TO to) (NP (NP (JJ marked) (NN downregulation)) (PP (IN of) (NP (NP (NN IL-8) (NN secretion)) (PRN (-LRB- -LRB-) (NP (QP (IN at) (JJS most) (CD 288) (CC +/-) (CD 152)) (NN ng/mL)) (-RRB- -RRB-)))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (TO to) (NP (NP (NN treatment)) (PP (IN with) (NP (NP (NP (NN IL-1) (NN beta)) (ADVP (RB alone))) (PRN (-LRB- -LRB-) (NP (QP (CD 919) (CC +/-) (CD 157)) (NN ng/mL)) (-RRB- -RRB-)))))))))))))))))))) (. .)))
(S1 (S (S (NP (PRP$ Our) (NNS results)) (VP (VBP indicate) (SBAR (SBAR (IN that) (S (NP (NN alpha-MSH)) (VP (VBZ exerts) (NP (JJ modulatory) (NNS effects)) (PP (IN on) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NP (NN NF-kappa) (NN B)) (CC and) (NP (NN AP-1))))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (PRP it)) (VP (MD can) (VP (VB regulate) (NP (NN chemokine) (NN secretion)) (PP (IN in) (NP (JJ human) (JJ dermal) (NNS fibroblasts)))))))))) (. .)))
(S1 (S (S (NP (NP (DT These) (NNS effects)) (PP (IN of) (NP (NN alpha-MSH)))) (VP (MD may) (VP (VB have) (NP (JJ important) (JJ regulatory) (NNS functions)) (PP (IN in) (NP (NP (JJ extracellular) (NN matrix) (NN composition)) (, ,) (NP (NN wound) (NN healing)) (, ,) (CC or) (NP (NN angiogenesis))))))) (. .)))
